Stockreport

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF COPENHAGEN, Denmark, January 7, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccine [Read more]